Home
Finance
Bank Routing Numbers
FedWire
Stock Portfolio Generator
Technical Analysis of Stocks
Best Months to Buy or Sell Stocks
Games
Hangman - Hang 'Em High
Chess
Shuttles Game
Chemistry
Chemical Equation Balancer
Periodic Table of the Elements
Chemical Bond Polarity Calculator
Linear Algebra
Gauss-Jordan Elimination Calculator
Calculate Pivots
Factorize: A=LU
Inverse Matrix Calculator
Null Space Calculator
Column Space Calculator
Row Space Calculator
Multiply Two Matrices
AI
Genetic Algorithms
Genetic Algorithms Stock Portfolio Generator
Shuttles Game
Tic-Tac-Toe Game
Personality Profile
Checkers Game
Scripts
Scan for all machines running IIS in a domain
Extract data from a Microsoft Word document
Outlook Scripts
Excel Scripts
IT
How to Stop a DDOS Attack
Subnet Calculator
Fingerprint Web Server
Whois Lookup
InternetPeriscope
About
My Favorite Links
Resume
View My Profile on LinkedIn
View My Profile on DataCamp
View My Profile on Pluralsight
Back to Companies who have applied for FDA Drug Approval
FDA Drug Approval Applications Sponsored by BAYER PHARMS
Application Number
Drugs/Products
Application Type
Most Recent Label Available Flag
Current Patent Flag
Action Type
Chemical Type
Ther Potential
Orphan Code
009585
CORT-DOME
New Drug Application
Approval
New manufacturer
(S) Standard review drug
009895
CORT-DOME
New Drug Application
Approval
New manufacturer
(S) Standard review drug
010010
STILPHOSTROL
New Drug Application
Approval
New ester, new salt, or other noncovalent derivative
(S) Standard review drug
017405
SOY-DOME
New Drug Application
Approval
New manufacturer
(S) Standard review drug
017846
RADIO-IODINATED (I 125) SERUM ALBUMIN (HUMAN)
New Drug Application
Approval
New manufacturer
(S) Standard review drug
017914
TRIDESILON
New Drug Application
Approval
New formulation
(S) Standard review drug
018669
NICLOCIDE
New Drug Application
Approval
New molecular entity (NME)
(P) Priority review drug
018833
LITHANE
New Drug Application
Approval
New manufacturer
(S) Standard review drug
018869
NIMOTOP
New Drug Application
Approval
New molecular entity (NME)
(P) Priority review drug
019069
MYCELEX-G
New Drug Application
Approval
New formulation
(S) Standard review drug
019478
ADALAT
New Drug Application
Approval
New manufacturer
(S) Standard review drug
019585
MIXTARD HUMAN 70/30
New Drug Application
Approval
New manufacturer
(S) Standard review drug
019858
CIPRO IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
New Drug Application
Approval
New formulation
(S) Standard review drug
020740
BAYCOL
New Drug Application
Approval
New molecular entity (NME)
(S) Standard review drug
021334
AVELOX
New Drug Application
Approval
New indication
(S) Standard review drug
021554
CIPRO XR
New Drug Application
Approval
New indication
(S) Standard review drug
050233
CANDEX
New Drug Application
Approval
New formulation
(S) Standard review drug
050235
NYSTAFORM
New Drug Application
Approval
050237
NEO-CORT-DOME
New Drug Application
Approval
050238
NEO-CORT-DOME
New Drug Application
Approval
050549
MEZLIN
New Drug Application
Approval
New molecular entity (NME)
(S) Standard review drug
050562
AZLIN
New Drug Application
Approval
New molecular entity (NME)
(S) Standard review drug
061810
CANDEX
Abbreviated New Drug Application
Approval
062333
MEZLIN
Abbreviated New Drug Application
Approval
062372
MEZLIN
Abbreviated New Drug Application
Approval
062388
AZLIN
Abbreviated New Drug Application
Approval
062417
AZLIN
Abbreviated New Drug Application
Approval
062697
MEZLIN
Abbreviated New Drug Application
Approval
080293
DELTA-DOME
Abbreviated New Drug Application
Approval
080438
HC #1
HC #4
Abbreviated New Drug Application
Approval
080972
VI-DOM-A
Abbreviated New Drug Application
Approval
083381
ANTAGONATE
Abbreviated New Drug Application
Approval
084476
DOMEBORO
Abbreviated New Drug Application
Approval
Back to Companies who have applied for FDA Drug Approval